Overt activation of NLRP3 inflammasome exacerbated hepatic steatosis, whereas defective inflammasome activation exhibited significant improvement of hepatocyte steatosis, inflammation, and fibrogenesis [10]. The gene discussed is NLRP3; the disease is fatty liver disease.